125 related articles for article (PubMed ID: 16092438)
1. Pyrimidines as the potential circulatory drugs.
Cieplik J
Acta Pol Pharm; 1992; 49(4):67-71. PubMed ID: 16092438
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of some 2-substituted triazolo[1,5-a]pyrimidin-7(4H)one-6-carboxylic acid ethyl esters.
El-Tahir KE; Al-Khamees HA; Bayomi SM
Boll Chim Farm; 1995 Dec; 134(11):604-8. PubMed ID: 8820975
[TBL] [Abstract][Full Text] [Related]
3. Pyrimidines as the cytostatic drugs.
Cieplik J
Acta Pol Pharm; 1992; 49(4):51-7. PubMed ID: 16092436
[TBL] [Abstract][Full Text] [Related]
4. Pyrimidines as the chemotherapeutic drugs.
Cieplik J; Królicki ZA
Acta Pol Pharm; 1992; 49(4):59-66. PubMed ID: 16092437
[TBL] [Abstract][Full Text] [Related]
5. New potential inhibitors of cyclin-dependent kinase 4: design and synthesis of pyrido[2,3-d]pyrimidine derivatives under microwave irradiation.
Tu S; Zhang J; Zhu X; Xu J; Zhang Y; Wang Q; Jia R; Jiang B; Zhang J
Bioorg Med Chem Lett; 2006 Jul; 16(13):3578-81. PubMed ID: 16621547
[TBL] [Abstract][Full Text] [Related]
6. Novel C-6 fluorinated acyclic side chain pyrimidine derivatives: synthesis, (1)H and (13)C NMR conformational studies, and antiviral and cytostatic evaluations.
Prekupec S; Makuc D; Plavec J; Suman L; Kralj M; Pavelić K; Balzarini J; Clercq ED; Mintas M; Raić-Malić S
J Med Chem; 2007 Jun; 50(13):3037-45. PubMed ID: 17539622
[TBL] [Abstract][Full Text] [Related]
7. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
Xie F; Zhao H; Zhao L; Lou L; Hu Y
Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and related agents.
Mátyus P
Pharmazie; 2001 Oct; 56 Suppl 1():S50-5. PubMed ID: 11686092
[TBL] [Abstract][Full Text] [Related]
10. Discovery of imidazole vinyl pyrimidines as a novel class of kinase inhibitors which inhibit Tie-2 and are orally bioavailable.
Buttar D; Edge M; Emery SC; Fitzek M; Forder C; Griffen A; Hayter B; Hayward CF; Hopcroft PJ; Luke RW; Page K; Stawpert J; Wright A
Bioorg Med Chem Lett; 2008 Aug; 18(16):4723-6. PubMed ID: 18676144
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antibacterial properties of 1,2,3-aryl-1,2,3,4-tetrahydropyrimido[4,5-d]pyrimidine derivatives.
Cieplik J; Raginia M; Pluta J; Gubrynowicz O; Bryndal I; Lis T
Acta Pol Pharm; 2008; 65(4):427-34. PubMed ID: 19051583
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antifungal activity and CoMFA analysis of novel 1,2,4-triazolo[1,5-a]pyrimidine derivatives.
Chen Q; Zhu XL; Jiang LL; Liu ZM; Yang GF
Eur J Med Chem; 2008 Mar; 43(3):595-603. PubMed ID: 17618711
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
Rostom SA; Ashour HM; Abd El Razik HA
Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
[TBL] [Abstract][Full Text] [Related]
14. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
Waelchli R; Bollbuck B; Bruns C; Buhl T; Eder J; Feifel R; Hersperger R; Janser P; Revesz L; Zerwes HG; Schlapbach A
Bioorg Med Chem Lett; 2006 Jan; 16(1):108-12. PubMed ID: 16236504
[TBL] [Abstract][Full Text] [Related]
15. Antagonists of the human adenosine A2A receptor. Part 2: Design and synthesis of 4-arylthieno[3,2-d]pyrimidine derivatives.
Gillespie RJ; Cliffe IA; Dawson CE; Dourish CT; Gaur S; Giles PR; Jordan AM; Knight AR; Lawrence A; Lerpiniere J; Misra A; Pratt RM; Todd RS; Upton R; Weiss SM; Williamson DS
Bioorg Med Chem Lett; 2008 May; 18(9):2920-3. PubMed ID: 18407496
[TBL] [Abstract][Full Text] [Related]
16. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity.
Gasse C; Douguet D; Huteau V; Marchal G; Munier-Lehmann H; Pochet S
Bioorg Med Chem; 2008 Jun; 16(11):6075-85. PubMed ID: 18467107
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of the human A(2A) adenosine receptor. 4. Design, synthesis, and preclinical evaluation of 7-aryltriazolo[4,5-d]pyrimidines.
Gillespie RJ; Bamford SJ; Botting R; Comer M; Denny S; Gaur S; Griffin M; Jordan AM; Knight AR; Lerpiniere J; Leonardi S; Lightowler S; McAteer S; Merrett A; Misra A; Padfield A; Reece M; Saadi M; Selwood DL; Stratton GC; Surry D; Todd R; Tong X; Ruston V; Upton R; Weiss SM
J Med Chem; 2009 Jan; 52(1):33-47. PubMed ID: 19072055
[TBL] [Abstract][Full Text] [Related]
18. New potential calcium channel modulators: design and synthesis of compounds containing two pyridine, pyrimidine, pyridone, quinoline and acridine units under microwave irradiation.
Tu S; Miao C; Fang F; Youjian F; Li T; Zhuang Q; Zhang X; Zhu S; Shi D
Bioorg Med Chem Lett; 2004 Mar; 14(6):1533-6. PubMed ID: 15006397
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors.
Ducray R; Ballard P; Barlaam BC; Hickinson MD; Kettle JG; Ogilvie DJ; Trigwell CB
Bioorg Med Chem Lett; 2008 Feb; 18(3):959-62. PubMed ID: 18182285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
